Take part in research studies

We need thousands of people with and without dementia to take part in research. This could be taking part in a drug trial or simply giving a blood sample, completing a questionnaire or having a brain scan.

Join Dementia Research

Join Dementia Research (JDR) is a service provided by the National Institute of Health and supported in partnership by Alzheimer's Society and Alzheimer's Research UK.

JDR matches people who are interested in research to research studies taking place across the UK. 

Who can sign up?

Anyone with or without dementia can sign up to Join dementia research. It is also possible for people to sign up on behalf of someone else.

Alternatively, Anyone interested in research and JDR can call our National Dementia Helpline on 0300 222 1122 and ask for a call back from the JDR Helpdesk. 

Join dementia research logo

Find out more and sign up to Join dementia research

Join dementia research

Our research studies looking for participants 

1. Evaluating liraglutide in Alzheimer's disease

This trial is finding out whether the diabetes drug Liraglutide could have benefits for people in early-stage Alzheimer's disease. The trial is looking for people in the early stages of Alzheimer's disease, and who don't have diabetes, to take part. 

To find out more, please contact the researchers at [email protected] or call them on 0208 383 3704.

2. SYMBAD - Study of Mirtazapine or Carbamazepine for Agitation in Dementia

Researchers based at the University of East Anglia and Brighton and Sussex Medical School are testing whether the medications mirtazapine or carbamazepine, which are licenced for depression and seizures respectively, can help to safely and effectively manage agitation in Alzheimer's disease. 

The researchers are looking for people with Alzheimer's disease and who have symptoms of agitation to join the trial. The participant will need to have a carer who can assist with some of the assessments.

The study is recruiting in Sussex, Norfolk, Gateshead, Manchester, North London, Birmingham, Cambridge, Surrey and Exeter.

Participants will be randomly assigned to receive one of the drugs or a placebo (inactive) drug. . The participants will be asked to take 1 tablet for the first 2 weeks of treatment in the trial, 2 tablets in the next 2 weeks and 3 tablets for the remaining 8 weeks treatment period (unless there are concerns about side effects resulting from them taking the medication).

To find out more, please see the study's website

1. Who to tell, how and when?

The aim of our Alzheimer's Society funded research study is to develop and deliver a programme to support people living with dementia who are fearful of disclosing their diagnosis to others. We are consulting with people living with dementia, their supporters (e.g. carers, family, friends) and members of the public who are not affected by dementia, to understand their views on disclosing a diagnosis of dementia. By participating in this consultation, you guide the direction of our research.

You can find the survey here.

If you have any questions about this public consultation or study please feel free to contact Jem Bhatt from the Research Department of Clinical Educational and Health Psychology at the University College London. (Direct Telephone: 020 7679 8275, Email: [email protected])

2. TIHM for dementia

The TIHM (Technology Integrated Health Management) for dementia study is trialling the use of technology to help clinicians and healthcare professionals to monitor people's well-being remotely. The technology would allow the clinical teams to take appropriate action if any alerts are raised.  The aim of the study is to show how this type of monitoring using the technological devices installed into the homes of participants may help to keep people living with dementia at home for longer and reduce hospital stays. The study will also evaluate the impact on carers.  

The study is only open to people living in Surrey or NE Hants at this time.  

To take part, you need a confirmed diagnosis of mild or moderate dementia - this will be confirmed by an MMSE test as part of the study. Participants will need to be living independently (not in assisted housing or care homes) and they must have a carer who is also willing to sign up to the study although they do not need to be a live-in carer.  

Participants will take part in the trial for a 6 month period. Read the participant information sheet

To express your interest in this study, please fill in the form on the website.

If you would like to talk to someone about the study, please  call 01932 722247 or email [email protected]

1. 100,000 Genomes

This study is aiming to understand more about the genetics of dementia. The researchers are looking for people with a diagnosis of dementia that was made before the person was 60 years old, or people who have dementia and had or have a close relative (parent, grandparent or sibling) with the same type of dementia. 

There is more information on the study page.

Thank you for your interest in helping with important research. If you have any questions please contact us at [email protected]

1. Caregiving HOPE

We are funding a study that is investigating how willingness and obligation to care for someone with dementia affects the carer over time.

The researchers are looking for people who are not currently caring for a person with dementia to fill in a short survey about how willing and prepared they feel to care for a person in the future. 

The results of this project will help us to understand how to prepare people as much as possible for taking on a caring role. 

The survey is open to anyone over the age of 18 who lives in the UK and is not currently caring for a relative with dementia.

For more information about the Caregiving HOPE study, please see the study's website.

Think this page could be useful to someone? Share it:

Further reading